Fund managers, page-1459

The health supplement sector continues to do well.
Both EZZ and Biome are reaching a new 52 weeks high today.
That may look surprising as consumer spending are now under pressure.
So, I would need to look at the sector into more details to see if the good results of these 2 companies are due to the fact that they are at early stage of their growth, or if it is also due to the growth of the sector (in that case, more considered as health related than discretionary spendings).

Both companies are doing well in the short term :
- strong top line growth (70 % for EZZ and at least 50 % for Biome), organic growth only (not sure about Biome),
- both companies are also profitable : for the second consecutive quarter for Biome and, on a more regular basis, for EZZ.
The major difference between the 2 companies is their valuation : 10 x sales for Biome vs around 1 x for EZZ.